Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Deferoxamine Plus Chemotherapy
Sponsor: Sun Yat-sen University